SELE and acute coronary syndrome: This result was also observed by other authors, whom also did not associate soluble E-selectin with adverse clinical outcomes in 855 patients diagnosed with stable carotid atherosclerosis 2 or in a study evaluating 65 patients with acute coronary syndrome 22.